These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11829579)

  • 1. Double blind, you are the weakest link--good-bye!
    Devereaux PJ; Bhandari M; Montori VM; Manns BJ; Ghali WA; Guyatt GH
    ACP J Club; 2002; 136(1):A11. PubMed ID: 11829579
    [No Abstract]   [Full Text] [Related]  

  • 2. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 4. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge.
    Chinchilli VM; Fisher L; Craig TJ
    J Allergy Clin Immunol; 2005 Mar; 115(3):592-7. PubMed ID: 15753909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trials. When and why: the principle of randomization and double-blind method].
    de Giuli F
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):973-5. PubMed ID: 12497860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Randomized controlled trials].
    Bornkessel B
    Med Monatsschr Pharm; 1997 Jun; 20(6):158-60. PubMed ID: 9289628
    [No Abstract]   [Full Text] [Related]  

  • 7. Double blind, you have been voted off the island!
    Devereaux PJ; Bhandari M; Montori VM; Manns BJ; Ghall WA; Guyatt GH
    Evid Based Ment Health; 2002 May; 5(2):36-7. PubMed ID: 12026889
    [No Abstract]   [Full Text] [Related]  

  • 8. Regarding "omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study".
    Gilbert DL
    Biol Psychiatry; 2008 Jan; 63(2):e13; author reply e15. PubMed ID: 17555722
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic ilioinguinal neurectomy in open inguinal hernia repair: a double-blind randomized controlled trial.
    Lange JF; Wijsmuller A; van Geldere D
    Ann Surg; 2007 Dec; 246(6):1116. PubMed ID: 18043120
    [No Abstract]   [Full Text] [Related]  

  • 10. Blinding in clinical trials, time to do it better.
    Park J; Bang H; Cañette I
    Complement Ther Med; 2008 Jun; 16(3):121-3. PubMed ID: 18534323
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 12. [Randomized controlled trials: a controversial past and a future of regulation and rejection].
    Strippoli GF; Manno C; Schena FP
    G Ital Nefrol; 2002; 19(1):4-12. PubMed ID: 12165939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning of clinical trials.
    Boissel JP
    J Intern Med; 2004 Apr; 255(4):427-38. PubMed ID: 15049877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized controlled study of bilateral cerebellar stimulation.
    Kellinghaus C; Loddenkemper T
    Epilepsia; 2006 Jul; 47(7):1247; author reply 1248-9. PubMed ID: 16886991
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Richards BA; Jensen
    Neurology; 2007 Mar; 68(12):963; author reply 963-4. PubMed ID: 17372141
    [No Abstract]   [Full Text] [Related]  

  • 17. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
    O'Brien C
    J Viral Hepat; 2006 May; 13 Suppl 1():6-14. PubMed ID: 16630042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.